» Articles » PMID: 10459809

Antibiotic Susceptibility Assay for Staphylococcus Aureus in Biofilms Developed in Vitro

Overview
Date 1999 Aug 25
PMID 10459809
Citations 67
Authors
Affiliations
Soon will be listed here.
Abstract

Four slime-producing isolates of Staphylococcus aureus were used in an antibiotic susceptibility assay for biofilms developed on 96-well polystyrene tissue culture plates. The study involved 11 antibiotics, two biofilm ages (6 and 48 h), two biofilm growth media (tryptone soy broth (TSB) and delipidated milk) and three antibiotic concentrations (4 x MBC, 100 mg/L and 500 mg/L). ATP-bioluminescence was used for automated bacterial viability determination after a 24 h exposure to antibiotics, to avoid biofilm handling. Under the conditions applied, viability in untreated biofilms (controls) was lower when biofilm growth was attempted in milk rather than in TSB. Various antibiotics had a greater effect on viability when used at higher (> or =100 mg/L) antibiotic concentrations and on younger (6 h) biofilms. Increased antibiotic effect was observed in milk-grown rather than TSB-grown biofilms. Phosphomycin and cefuroxime, followed by rifampicin, cefazolin, novobiocin, vancomycin, penicillin, ciprofloxacin and tobramycin significantly affected biofilm cell viability at least under some of the conditions tested. Gentamicin and erythromycin had a non-significant effect on cell viability. Transmission electron microscopy revealed that cells at the inner biofilm layers tend to remain intact after antibiotic treatment and that TSB-grown biofilms favoured a uniformity of cell distribution and increased cell density in comparison with milk-grown biofilms. A reduced matrix distribution and enhanced cell density were observed as the biofilm aged. The S. aureus biofilm test discriminated antibiotics requiring shorter (3 h or 6 h) from those requiring longer (24 h) exposure and yielded results which may be complementary to those obtained by conventional tests.

Citing Articles

Antibiotics with antibiofilm activity - rifampicin and beyond.

Ferreira L, Pos E, Nogueira D, Ferreira F, Sousa R, Abreu M Front Microbiol. 2024; 15:1435720.

PMID: 39268543 PMC: 11391936. DOI: 10.3389/fmicb.2024.1435720.


Effective biofilm eradication in MRSA isolates with aminoglycoside-modifying enzyme genes using high-concentration and prolonged gentamicin treatment.

Ando K, Miyahara S, Hanada S, Fukuda K, Saito M, Sakai A Microbiol Spectr. 2024; 12(10):e0064724.

PMID: 39191399 PMC: 11448082. DOI: 10.1128/spectrum.00647-24.


Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S. aureus infection with osseointegration in murine models of implant-associated osteomyelitis.

Ren Y, Weeks J, Xue T, Rainbolt J, Bentley K, Shu Y Bone Res. 2023; 11(1):51.

PMID: 37848449 PMC: 10582111. DOI: 10.1038/s41413-023-00287-4.


Influence of surface characteristics of implant materials on MRSA biofilm formation and effects of antimicrobial treatment.

van Dun S, Verheul M, Pijls B, van Prehn J, Scheper H, Galli F Front Microbiol. 2023; 14:1145210.

PMID: 37152752 PMC: 10159048. DOI: 10.3389/fmicb.2023.1145210.


Antimicrobial Peptides and Small Molecules Targeting the Cell Membrane of Staphylococcus aureus.

Ganesan N, Mishra B, Felix L, Mylonakis E Microbiol Mol Biol Rev. 2023; 87(2):e0003722.

PMID: 37129495 PMC: 10304793. DOI: 10.1128/mmbr.00037-22.